Volume 21, Number 5—May 2015
Transmission of Hepatitis C Virus among Prisoners, Australia, 2005–2012
|Cluster||Transmission, participant ID no.||Period of co-location||Prison ID†||Patient ID||Est. date of infection||HCV genotype||ATSI||Continuously in prison‡||Equipment sharing§||OST§||Heroin use§|
|A||315 → 117||2007 Dec 31–2008 Jan 22||AT||315||2007 Oct 30||1a||No||Yes||Yes||No||No|
|117||2008 Feb 27||1a||No||No||Yes||No||Yes|
|315 → 461||2008 Jun 29–Jul 11||AE||315||2007 Oct 30||1a||No||Yes||Yes||No||No|
|2008 Sep 24–Oct 1||461||2008 Oct 6||1a||No||No||Yes||No||Yes|
|B||304 → 357||2007 Oct 26–Nov 23||AB||304||2007 Apr 17||3a||No||No||No||No||No|
|357||2008 Nov 11||3a||No||Yes||Yes||No||Yes|
|C||302 → 426||2008 Dec 9–18||AP||302§||2007 Oct 11||3a||Yes||No||Yes||No||No|
|426||2008 Dec 21||3a||Yes||No||Yes||Yes||No|
*All prisoners were injection drug users during the period of co-location. ATSI, Aboriginal and/or Torres Strait Islander descent; est., estimated; HCV, hepatitis C virus; ID, identification; OST, opioid substitution therapy.
†Prisons are identified by codes for de-identification purposes.
‡Continuously in prison 6 mo before estimated date of infection.
§Female patient. All others were male.
1Additional HITS-p investigators are listed at the end of this article.